Anyone waiting for Big Pharma to stumble on the industry’s so-called “patent cliff” has been heartily disappointed. In spite of many high-revenue products facing patent expirations in the next few years, the group continues to be a top performer, lifting the health care sector to a market-beating 9% gain by… Read More
Michael Vodicka is the president and founder of the Vodicka Group Inc., a registered investment advisor (RIA) that specializes in providing customized investment solutions to individual and institutional investors. Before becoming a small business owner and entrepreneur, he developed fixed-income investment strategies for a multi-billion dollar brokerage firm and spent five years as an equity portfolio manager for a private investment research company. Mike graduated from the University of Kansas with a degree in business communications and is a licensed investment advisor (Series 65). He loves sharing his passion for the market and investing with clients and readers alike.